Trials / Completed
CompletedNCT03595254
Digital Cognitive Behavior Therapy Program for Suicide Prevention
Thrive-Montana: A Computerized Cognitive Behavior Therapy (cCBT) Program to Reduce Depression, Anxiety, Suicidal Ideation and Behaviors for Rural Montanans
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 725 (actual)
- Sponsor
- Montana State University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study evaluates the efficacy of Thrive, a computerized cognitive behavior therapy program, to reduce depression and anxiety symptoms and to reduce suicidal thinking among adults. The first 450 participants will participate in a randomized waitlist controlled trial. The remaining 550 participants will be provided the program immediately upon enrolling
Detailed description
The efficacy of Thrive has been studied among patient and community populations and has shown to effectively reduce depression and anxiety symptoms among adults with moderate to severe depression symptoms at baseline. This study will examine whether Thrive can also reduce suicidal thinking for persons exhibiting at least moderate depression symptoms. The first phase of the study will implement a randomized waitlist controlled trial. The second phase of the study will examine the effects in a open trial. Outcome assessments will occur at baseline, 4- and 8-weeks (12- and 16-weeks for the waitlist group) with a 6-month follow-up assessment for all participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Thrive | Computerized Cognitive Behavior Therapy program |
Timeline
- Start date
- 2018-11-16
- Primary completion
- 2020-04-08
- Completion
- 2020-04-08
- First posted
- 2018-07-23
- Last updated
- 2020-09-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03595254. Inclusion in this directory is not an endorsement.